ARCA Cap Analog, ≥98%, 10 µl, confezione in plastica.

2-Chloroisoindoline-1,3-dione, 97.00%, 5g

2-Benzyl-2,7-diazaspiro[4.4]nonane-1,3-dione hydrochloride, 95.0%, 1g

2-Amino-5-fluoronicotinic acid, 95.0%, 100mg

3,5-Dibromobenzyl Bromide>95.0%(GC)25g

1-[2-(1-Pyrrolidinyl)ethyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 250mg

2-Chloro-5-methylpyridine-4-boronic acid, 97%, 5g

3-cyclopropyl-1,2-oxazole-4-carboxylic acid, 95.0%, 100mg

3-Methylglutaric anhydride, 96.0%, 500g

6-Bromo-4-chloro-quinoline-3-carbonitrile, 97.0%, 100mg

Bruceine D, 99.53%, 100mg

tert-Butyl (5-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)pent-4-yn-1-yl)carbamate, 98%, 1g

Palladium hydroxide on carbon 5%, 95.0%, 25g